| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/27/1997 | WO1997007225A2 High efficiency retroviral packaging system |
| 02/27/1997 | CA2229847A1 High efficiency retroviral packaging system |
| 02/26/1997 | EP0759072A1 Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants |
| 02/26/1997 | EP0552267B1 Engineered bacteriophages and vaccines containing them |
| 02/26/1997 | EP0437537B1 Bacterial detection by phage transduction of detectable phenotype |
| 02/26/1997 | CA2184019A1 Insecticidal matrix and process for preparation thereof |
| 02/25/1997 | US5605827 Infectious bursal disease virus VP2 fusion protein expressed by baculovirus |
| 02/25/1997 | US5605792 Genetic engineering |
| 02/25/1997 | US5605692 Polypeptide |
| 02/20/1997 | WO1997006272A2 High efficiency helper system for aav vector production |
| 02/20/1997 | WO1997006271A1 Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 02/20/1997 | WO1997006270A1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS |
| 02/20/1997 | WO1997006260A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/20/1997 | WO1997006243A1 Method for purifying viruses by chromatography |
| 02/20/1997 | CA2201282A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/19/1997 | EP0758397A1 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 02/18/1997 | US5604093 Isolated new human herpes virus having morphology of human herpes virus and genomic double-stranded dna which hybridizes under stringent conditions with nucleic acid of specified molecular clone |
| 02/13/1997 | WO1997005263A1 Helper virus-free herpesvirus vector packaging system |
| 02/13/1997 | WO1997005255A2 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | WO1997005242A1 Novel replication competent human immunodeficiency virus type 2 (hiv-2) proviral clone designated hiv-2kr |
| 02/13/1997 | WO1997004804A1 Avirulent herpetic viruses useful as tumoricidal agents and vaccines |
| 02/13/1997 | WO1997004803A1 Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine |
| 02/13/1997 | CA2226860A1 Novel replication competent human immunodeficiency virus type 2 (hiv-2) proviral clone designated hiv-2kr |
| 02/13/1997 | CA2225551A1 Helper viruses for preparing recombinant viral vectors |
| 02/12/1997 | EP0757722A1 HERPES VIRUS TRANSFORMED TO EXPRESS gD $i(IN VITRO) |
| 02/12/1997 | EP0757717A1 Papillomavirus vaccines |
| 02/11/1997 | US5602242 Genetic engineered, encapsidated protein shell transfecting the plant cells |
| 02/11/1997 | US5602023 Centrifuging to produce pellet; purification by sucrose gradient ultracentrifugation; rehydration; adding modified starch as protective colloid; lyophilization |
| 02/11/1997 | US5602022 Production of infectious bursal disease virus in mammalian cell line |
| 02/11/1997 | US5601974 Method of detecting viral infection in vaccinated animals |
| 02/06/1997 | WO1997004119A1 Viral vectors and line for gene therapy |
| 02/06/1997 | WO1997004099A2 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 02/06/1997 | WO1997004076A1 Synthetic hpv11 virus-like particles |
| 02/06/1997 | WO1997003706A1 Method and apparatus for inactivating contaminants in blood products |
| 02/06/1997 | CA2227339A1 Synthetic hpv11 virus-like particles |
| 02/06/1997 | CA2200696A1 Viral vectors and line for gene therapy |
| 02/05/1997 | EP0756631A1 Method of eliminating genetic routes for bacteriophage evolution and products produced thereby |
| 02/05/1997 | CN1142187A Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 02/05/1997 | CN1141953A Formation of plasmid-type herpes-virus carrier for specific expression of human nerve cell and usage of same |
| 02/04/1997 | US5599691 Herpes simplex virus as a vector |
| 01/30/1997 | WO1997003187A2 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 01/30/1997 | CA2226362A1 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 01/29/1997 | EP0755441A1 Antibacterial therapy with genotypically modified bacteriophage |
| 01/29/1997 | EP0755440A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 01/29/1997 | EP0755259A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
| 01/29/1997 | CN1141648A Biological control agent comprising an isolated polyhedrosis virus |
| 01/29/1997 | CN1141340A Recombinant DNA virus and method for prepn. thereof |
| 01/28/1997 | US5597896 Retrovirus human immunodeficiency virus type 2(HIV2), capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
| 01/28/1997 | US5597721 Preparation of antigens of and of vaccines for the virus of mystery disease, antigens and vaccines obtained for the prevention of this disease |
| 01/23/1997 | WO1997002355A1 Recombinant mva virus, and the use thereof |
| 01/22/1997 | EP0754226A1 Recombinant equine herpesviruses |
| 01/22/1997 | EP0754223A1 Non-pathogenic strains of hiv-1 |
| 01/22/1997 | EP0502107B1 Type-b rotavirus cultures and uses thereof |
| 01/21/1997 | US5595739 Hepatitis B virus mutants, reagents and methods for detection |
| 01/21/1997 | CA2009505C Inhibitor of herpesvirus adsorption |
| 01/21/1997 | CA1338857C Yeast vector featuring antibiotic resistance and chromosomal integration |
| 01/16/1997 | WO1997001358A1 Tissue specific viral vectors |
| 01/16/1997 | WO1997001357A1 Encapsulated cells producing viral particles |
| 01/16/1997 | WO1996027677A3 Method of purification of recombinant viral vectors containing a therapeutic gene |
| 01/16/1997 | CA2222559A1 Encapsulated cells producing viral particles |
| 01/16/1997 | CA2222457A1 Tissue specific viral vectors |
| 01/15/1997 | EP0753581A1 Improved recombinant eukaryotic cytoplasmic viruses, method for their production and their use as vaccines |
| 01/15/1997 | EP0753067A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF) |
| 01/15/1997 | EP0752887A1 Immunodeficiency recombinant poxvirus |
| 01/15/1997 | EP0617737B1 Method for selecting recombinant micro-organisms of which the surface comprises at least one molecule having enzymatic activity |
| 01/15/1997 | EP0491930B1 Primate lentivirus vaccines |
| 01/15/1997 | CN1140410A Vitamin E and derivs. preventing damage in red cells sterilized by phthalocyanines and light |
| 01/15/1997 | CN1140201A Autonomously replicating vector for construction of recombinant adenovirus concomitant virus packaging system and use thereof |
| 01/14/1997 | US5593883 Ancient microorganisms |
| 01/14/1997 | US5593825 Hepatitis B virus mutants, reagents and methods for detection |
| 01/14/1997 | US5593669 Pesticide, insecticide |
| 01/09/1997 | WO1997000947A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
| 01/09/1997 | WO1997000696A1 Low pathogenicity prrs live virus vaccines and methods of preparation thereof |
| 01/09/1997 | WO1996038556A3 Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer |
| 01/09/1997 | CA2222270A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
| 01/08/1997 | EP0752004A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 01/08/1997 | EP0752003A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 01/08/1997 | EP0752001A1 Biological insect control agent |
| 01/08/1997 | EP0752000A1 Packaging-deficient lentiviruses |
| 01/08/1997 | EP0751988A1 Highly efficient production and isolation of viral particles |
| 01/07/1997 | US5591823 Expression of specific immunogens using viral antigens |
| 01/07/1997 | US5591624 Retroviral packaging cell lines |
| 01/07/1997 | US5591574 Probes, diagnostic method and immunization method based on papillomavirus types HPV 49 and HPV 50 |
| 01/07/1997 | US5591440 Hepatitis B Virus mutants, reagents and methods for detection |
| 01/03/1997 | WO1997000326A1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 01/03/1997 | WO1997000322A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 01/03/1997 | WO1997000088A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | CA2224697A1 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | CA2224645A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 01/02/1997 | EP0750676A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
| 01/02/1997 | EP0750675A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
| 01/02/1997 | EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b)) |
| 01/02/1997 | EP0750669A1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM |
| 01/02/1997 | DE19526386C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them |
| 12/31/1996 | US5589377 Cells and genetic engineering |
| 12/27/1996 | WO1996041874A1 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 12/27/1996 | WO1996041606A2 Improved pharmaceutical compositions for gene therapy |
| 12/27/1996 | WO1996041529A1 Compositions and methods for use in controlling insect populations |
| 12/27/1996 | EP0750041A2 HIV-2 nucleotide sequences |
| 12/24/1996 | US5587490 Method of inactivation of viral and bacterial blood contaminants |